Recent studies highlighted that Notch1 and Ras/MAPK pathways are associated with development, progression, CSCs maintenance, and chemotherapy resistant of BC (Dontu et al., 2004; Zhong et al., 2016). The gene discussed is NOTCH1; the disease is breast cancer.